Medications that can be used to treat HAE attacks include pdC1-INH; recombinant human C1 inhibitor; ecallantide, a kallikrein inhibitor; and icatibant, a bradykinin B2 receptor inhibitor [1]. The gene discussed is KLK4; the disease is hereditary angioedema.